Mercalis is an integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain. The company partners closely with its clients to deliver an end-to-end spectrum of commercial capabilities that work together seamlessly and flexibly. Backed by proven industry expertise and results-driven technology, Mercalis provides the data and strategic insights, patient support services, and healthcare provider engagement tools to help lif ...
…
continue reading
1
Biosimilars and their Impact on Pharma Patient Support Services
44:15
44:15
Na później
Na później
Listy
Polub
Polubione
44:15
Our Thanksgiving episode of Mercalis in Motion is now available! In this episode, Mercalis team members Michael Turner, Terry Cato, and Blake Johnson join us to discuss the impact the introduction of biosimilars has made on the pharmaceutical marketplace and how pharma manufacturers are developing strategy for biosimilar patient support services.…
…
continue reading
1
Mercalis Celebrates 15 Years of RxStudy Card
32:37
32:37
Na później
Na później
Listy
Polub
Polubione
32:37
On this episode of Mercalis in Motion, Sean Boyler, Tom Gottschalk, and Robbie Hill join us in the studio to commemorate the 15-year anniversary of RxStudy Card. What follows is a conversation about how RxStudy Card by Mercalis has evolved over the years to save our clients millions of dollars in time and money while eliminating waste associated wi…
…
continue reading
1
Simplifying eServices with Mercalis’s Curator Solution
48:26
48:26
Na później
Na później
Listy
Polub
Polubione
48:26
Today, Landy and Eric welcome three members of the Mercalis Products Team to the studio. Bill Dupere, Stephanie Chesebro, and Nick Hill stopped by to discuss recent developments related to the Mercalis eServices and Curator capabilities. In November 2023, Mercalis announced an exclusive perpetual license to a portfolio of access and adherence techn…
…
continue reading
In this episode, Heather Smith, PhD, RN, NNP visits the studio to discuss the Mercalis Nurse Network. For the past seven years, Mercalis has provided its clients and their patients with a growing suite of services focused on patient care and education. The need for our Nurse Network was realized when we observed that parents and caregivers were bei…
…
continue reading
1
Market Trends, AI Strategy, and More: A Conversation With Policy Reporter by Mercalis
48:12
48:12
Na później
Na później
Listy
Polub
Polubione
48:12
In this episode, Landy and Eric sit down with Jason Zemcik, Andrea Xu, and Bethany Najer of Policy Reporter by Mercalis to dive into a number of issues that are facing the life sciences market, as well as an update on Policy Reporter's offerings and what's on the horizon for the growing healthcare information management company . Tune in for a thou…
…
continue reading
1
Triangle Insights Group by Mercalis: A Discussion About the Inflation Reduction Act
26:19
26:19
Na później
Na później
Listy
Polub
Polubione
26:19
Today on Mercalis in Motion, we’re pleased to share an episode featuring our colleagues from Triangle Insights Group by Mercalis. Triangle Insights Group, acquired by Mercalis in April 2022, is a premier strategy consulting firm providing guidance on critical business issues to life science industry leaders. On this episode, Matt Haynes and Meghna …
…
continue reading
1
Mercalis Commemorates Rare Disease Day 2024
38:09
38:09
Na później
Na później
Listy
Polub
Polubione
38:09
Rare Disease Day is an observance that takes place worldwide to raise awareness for rare diseases and improve access to treatment and medical representation for individuals with rare diseases and their families. Rare Disease Day typically takes place on or near the last day of February. In this episode of Mercalis in Motion, Landy and Eric welcome …
…
continue reading
1
A Conversation With Mercalis CEO Scott Dulitz
31:28
31:28
Na później
Na później
Listy
Polub
Polubione
31:28
Mercalis CEO Scott Dulitz joins Landy and Eric for Mercalis in Motion’s first podcast episode of 2024. Scott reflects on a very eventful and successful 2023 as well as what lies ahead for the life sciences commercialization partner in 2024 and beyond.Autor: Mercalis
…
continue reading
1
2023 in Review: Noteworthy Guests and Key Discussions
28:36
28:36
Na później
Na później
Listy
Polub
Polubione
28:36
In this episode, our hosts Landy Townsend, Vice President of Marketing and Communications, and Eric Manning, Creative Director, take a look back at 2023, highlighting notable guests and key discussions from the past 12 months. No frills or fluff—just a recap of some of the people and topics that made an impact. Whether you're a regular listener or …
…
continue reading
1
Copay Accumulator Plan Designs: What Life Sciences Manufacturers Need to Know Heading into 2024
31:10
31:10
Na później
Na później
Listy
Polub
Polubione
31:10
Copay accumulators have been a major topic of discussion in the life sciences community for the past several years, and Mercalis has been extremely busy providing continued guidance and support to our clients who have been impacted. After several recent legal developments, we decided to devote an episode of our Mercalis in Motion podcast to discuss…
…
continue reading
In this episode of Mercalis in Motion, we welcome to the studio Mercalis CEO Scott Dulitz to discuss TrialCard’s recent rebranding initiative that resulted in the creation of Mercalis. Scott discusses the reasons that led to the rebranding, how we arrived at the name Mercalis, and what’s next for the growing integrated life sciences commercializati…
…
continue reading
1
Navigating Alternate Funding Programs
24:50
24:50
Na później
Na później
Listy
Polub
Polubione
24:50
Diana Villanova, TrialCard’s VP of Patient Support Services Strategy, joins Landy and Eric on today’s episode, to discuss Alternate Funding Programs (AFPs). Designed to limit plan sponsors’ financial exposure, the increased use of AFPs has introduced new access challenges for patients, plans, and manufacturers alike.…
…
continue reading
1
The Inflation Reduction Act (IRA) of 2022: What Pharmaceutical Manufacturers Need to Know
31:48
31:48
Na później
Na później
Listy
Polub
Polubione
31:48
The Drug Provisions within the Inflation Reduction Act (IRA) of 2022 are of critical importance to pharmaceutical manufacturers, who now have a host of new considerations when thinking through their portfolio strategies and pricing and market access considerations. In this episode of TrialCard TALK, Landy and Eric welcome to the studio two experts …
…
continue reading
1
TrialCard's Non-Commercial Dispensing Pharmacy
41:10
41:10
Na później
Na później
Listy
Polub
Polubione
41:10
In this episode of TrialCard TALK, we welcome to the studio Chris Harris, TrialCard's Vice President of Operations, to discuss the growth and impact that TrialCard's non-commercial dispensing pharmacy has had on the organization and its clients.Autor: TrialCard
…
continue reading
1
A Conversation with Dean Erhardt, president & CEO of D2 Solutions
39:58
39:58
Na później
Na później
Listy
Polub
Polubione
39:58
In this episode of TrialCard TALK, Landy and Eric welcome to the studio Dean Erhardt, President & CEO of D2 Solutions. D2 is a healthcare solutions company that leverages consulting expertise with SaaS-based technology tools to drive revenue, enhance operational efficiency, and decrease exposure to regulatory risk for pharma and biotech manufacture…
…
continue reading
TrialCard CEO Scott Dulitz joins Landy and Eric on the first podcast of 2023 to reflect upon TrialCard’s success in 2022 and look ahead at some of the trends in the market that will define 2023.Autor: TrialCard
…
continue reading
In the final episode of TrialCard TALK for 2022, our hosts Landy Townsend, Vice President of Marketing and Communications, and Eric Manning, Associate Creative Director, reflect on the guests we have featured during the year and some of the highlights from each insightful conversation. Download now to enjoy the best of our 2022 discussions.…
…
continue reading
1
Simplifying eServices with TrialCard’s Orchestrator solution
35:06
35:06
Na później
Na później
Listy
Polub
Polubione
35:06
In the latest episode of TrialCard TALK, we speak to Bill Dupere, VP for Product Development for Patient Services, and Stephanie Chesebro, Product Owner – eServices on our IT Development Team, about TrialCard’s eServices and ‘Orchestrator’ solution. Bill and Stephanie explain how Orchestrator allows our life science clients to access many eService …
…
continue reading
1
Policy Reporter: Demystifying Payer Coverage To Serve Patients
49:14
49:14
Na później
Na później
Listy
Polub
Polubione
49:14
In this episode of TrialCard TALK, we are joined by Tim Ogren, General Manager, and Peter Weissberg, Managing Director, at Policy Reporter – a TrialCard Company. Tim and Peter speak to us about the difference that the company makes to its clients – and ultimately, patients – through its innovative healthcare software solutions, which improve the wa…
…
continue reading
1
Creating a More Efficient Clinical Supply Process with TrialCard’s RxStudy Card
31:45
31:45
Na później
Na później
Listy
Polub
Polubione
31:45
In this episode of TrialCard TALK, Tom Gottschalk, Senior Director of Business Development for TrialCard, outlines how we support biotech and pharmaceutical companies’ clinical trial supply needs through our RxStudy Card™ – an innovative product that generates significant cost and time savings. Download this podcast to learn how TrialCard brings hi…
…
continue reading
1
Triangle Insights Group, a TrialCard Company
28:10
28:10
Na później
Na później
Listy
Polub
Polubione
28:10
Following TrialCard’s recent acquisition of Triangle Insights Group, Landy and Eric welcome two of the strategy consulting firm’s founding partners to the studio this month. In this discussion, we speak to Gautam Aggarwal and Chris Apolito about how Triangle’s strategic capabilities, combined with TrialCard’s industry-leading suite of patient suppo…
…
continue reading
1
TrialCard’s Nursing Team: A Difference Maker in Patient Services
27:22
27:22
Na później
Na później
Listy
Polub
Polubione
27:22
To commemorate National Nurses Week, Landy and Eric welcomed Heather Smith, PhD, RN, NNP to the studio to discuss the role that nurses play in TrialCard’s Patient Services offerings. Dr. Smith, who serves as Senior Program Director, Hub Services at TrialCard, also discusses nurses’ evolving roles through the years, the future of nursing, and what s…
…
continue reading
1
How EngageHCP by TrialCard Helps Increase Access to Health Care Providers
27:15
27:15
Na później
Na później
Listy
Polub
Polubione
27:15
In this episode of TrialCard TALK, Landy and Eric welcome to the studio Michael Carlin, General Manager of EngageHCP by TrialCard. The number of no see or difficult to see HCPs has risen dramatically in recent years and has been greatly exacerbated by COVID-19. Despite this growing trend, life science companies still must reach and educate HCPs abo…
…
continue reading
1
TrialCard’s State of the Union: March 2022
29:55
29:55
Na później
Na później
Listy
Polub
Polubione
29:55
In this episode of TrialCard TALK, Landy and Eric welcome TrialCard’s two most senior executives to the studio: Scott Dulitz, President & Chief Strategy Officer and Joe Abdalla, President & Chief Commercial Officer. Scott and Joe discuss TrialCard’s recent successes, future plans, and their vision for the full-service life sciences commercializatio…
…
continue reading
In this episode of TrialCard TALK, our hosts Landy Townsend, Vice President of Marketing and Communications, and Eric Manning, Associate Creative Director, reflect back on our guests from this first season and highlights from each conversation.Autor: TrialCard
…
continue reading
1
TrialCard's Digital Health Multi-Channel Engagement Platform
24:23
24:23
Na później
Na później
Listy
Polub
Polubione
24:23
In the latest episode of TrialCard TALK, Molly Stallings, Vice President of Product Marketing at TrialCard, discusses the evolving digital landscape and how it impacts the delivery of patient support programs. Download the podcast to hear how TrialCard is effectively engaging patients and caretakers with its life sciences multi-channel communicatio…
…
continue reading
1
TC Synapse: Co-Pay Program Risk Mitigation and Compliance Strategies for Pharmaceutical Manufacturers
38:02
38:02
Na później
Na później
Listy
Polub
Polubione
38:02
The risk environment facing co-pay assistance programs has expanded significantly in recent years. Legislative and policy developments, payer tactics, and ill-intentioned actors present financial, operational, and compliance issues if not properly understood and addressed. TrialCard’s TC Synapse suite combines industry-leading subject matter expert…
…
continue reading
1
TC Script: How TrialCard’s Non-Commercial Dispensing Pharmacy is Making a Difference for Patients
30:01
30:01
Na później
Na później
Listy
Polub
Polubione
30:01
In this episode of TrialCard TALK, Landy and Eric welcome Mark Boesen, J.D., Pharm.D. from TC Script, TrialCard's non-commercial dispensing pharmacy located in Scottsdale, AZ. Mark discusses how TC Script has continued TrialCard's longstanding promise to always take care of patients.Autor: TrialCard
…
continue reading
1
Dissecting the CMS Best Price Rule: What it Means for Manufacturer Co-Pay Programs
28:14
28:14
Na później
Na później
Listy
Polub
Polubione
28:14
In this podcast, Jason Zemcik, Sr. Director of Product Management at TrialCard, breaks down the implications of this rule, outlines strategies for manufacturers to address it, and provides insight on other drug pricing policy matters that could affect how manufacturers deliver patient support programs going forward. .…
…
continue reading
1
Diversity, Equity, and Inclusion: A Conversation With TrialCard
29:35
29:35
Na później
Na później
Listy
Polub
Polubione
29:35
In this episode, Latrinda Riley joins Landy Townsend, Vice President of Marketing at TrialCard, to discuss her new role as the Director of Diversity, Equity, and Inclusion. Listen to learn more about Latrinda’s background, how she managed challenges brought on by the COVID-19 pandemic, and the new initiatives she has planned for the organization.…
…
continue reading